Vaneck Vectors Pharmaceutical etf shares owned by Tower Research Capital
Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Vaneck Vectors Pharmaceutical etf
Tip: Access up to 7 years of quarterly data
All positions including Vaneck Vectors Pharmaceutical etf held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.0M | 22k | 90.36 |
| 2025-06-30 | $3.0M | 35k | 87.96 |
| 2025-03-31 | $911 | 10 | 91.10 |
| 2024-12-31 | $3.0M | 35k | 86.28 |
| 2024-09-30 | $2.8M | 29k | 95.04 |
| 2024-03-31 | $325k | 3.6k | 90.70 |
| 2023-09-30 | $1.3M | 17k | 79.86 |
| 2023-06-30 | $592k | 7.5k | 78.77 |
| 2023-03-31 | $2.3M | 30k | 77.63 |
| 2022-09-30 | $3.5M | 52k | 67.38 |
| 2022-06-30 | $371k | 4.8k | 76.81 |
| 2021-12-31 | $588k | 7.6k | 76.95 |
| 2021-09-30 | $1.3M | 18k | 72.80 |
| 2021-06-30 | $2.2M | 30k | 73.05 |
| 2021-03-31 | $900k | 13k | 68.63 |
| 2020-12-31 | $65k | 973 | 66.80 |
| 2020-09-30 | $32k | 507 | 63.12 |
| 2020-06-30 | $827k | 13k | 62.23 |
| 2019-12-31 | $893k | 14k | 64.15 |
| 2019-09-30 | $89k | 1.6k | 56.98 |
| 2019-06-30 | $2.5M | 42k | 58.74 |
| 2019-03-31 | $691k | 11k | 60.88 |
| 2018-12-31 | $294k | 5.6k | 52.63 |
| 2018-09-30 | $0 | 3.9k | 0.00 |
| 2018-06-30 | $1.6M | 27k | 59.76 |
| 2018-03-31 | $1.1M | 18k | 57.92 |
| 2017-12-31 | $1.8M | 31k | 59.34 |
| 2017-09-30 | $27k | 472 | 57.20 |
| 2017-06-30 | $980k | 17k | 59.08 |
| 2017-03-31 | $16k | 298 | 53.69 |
| 2016-12-31 | $9.0k | 167 | 53.89 |
| 2016-09-30 | $25k | 442 | 56.56 |
Top funds holding Vaneck Vectors Pharmaceutical etf
View all funds holding Vaneck Vectors Pharmaceutical etf